Clinical Trial Update: Phase 1 Dose Escalation of ArtemiCoffee [Phase 1]

View source ↗

Summary

Phase 1 dose-escalation trial of ArtemiCoffee in ovarian cancer has completed; this document provides an update on the study's status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• ArtemiCoffee

Snippet

Sponsor: Frederick R. Ueland, M.D. | Conditions: Ovarian Cancer | Phase 1 | Status: COMPLETED